insights_auto
Why is TCRX down 4.40%?
Dive Deeperchevron_right
TCRX:NASDAQ
Tscan Therapeutics Inc
$0.16
arrow_downward
-4.40%(-0.0074) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TCRX...
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
10.76M
Avg. vol.
547.00K
Volume
227.68K
52-wk high
$1.47
52-wk low
$0.16
EPS
-$0.91
Beta
1.21
Shares outstanding
63.50M
No. of employees
43
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
10.76M
Avg. vol.
547.00K
Volume
227.68K
52-wk high
$1.47
52-wk low
$0.16
EPS
-$0.91
Beta
1.21
Shares outstanding
63.50M
No. of employees
43
News stories
From web sources and news partners
Longbridge
·
2 days ago
[Weekly Recap] CTA Net Position Hits Extreme Low, Nasdaq…
BigGo Finance
·
7 hours ago
Wall Street's Oldest Lesson: Sitting Out the Market Beats Almost Nothing
Benzinga
·
3 hours ago
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
The Motley Fool
·
5 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
About Tscan Therapeutics Inc
CEO-
Employees43
Founded2018
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitetscan.com